Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-02-24 @ 12:11 AM
Study NCT ID:
NCT00655668
Status:
TERMINATED
Last Update Posted:
2019-11-25
First Post:
2008-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma
Sponsor:
Celgene
Organization: